Concepts (84)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tumor Suppressor Protein p53 | 4 | 2014 | 289 | 0.790 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 2 | 2008 | 44 | 0.730 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2008 | 181 | 0.670 |
Why?
|
| Genetics, Microbial | 1 | 2015 | 11 | 0.600 |
Why?
|
| Biotechnology | 1 | 2015 | 44 | 0.580 |
Why?
|
| Mitosis | 2 | 2008 | 205 | 0.390 |
Why?
|
| Chromosomal Instability | 1 | 2008 | 18 | 0.380 |
Why?
|
| Cell Polarity | 1 | 2007 | 97 | 0.350 |
Why?
|
| Mustard Gas | 1 | 2007 | 5 | 0.350 |
Why?
|
| DNA Damage | 2 | 2014 | 280 | 0.320 |
Why?
|
| DNA Repair | 2 | 2007 | 238 | 0.310 |
Why?
|
| Fibroblasts | 2 | 2007 | 326 | 0.300 |
Why?
|
| Fluorouracil | 1 | 2002 | 37 | 0.250 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2002 | 27 | 0.250 |
Why?
|
| Hypothermia, Induced | 1 | 2002 | 35 | 0.250 |
Why?
|
| Myoblasts | 1 | 2022 | 54 | 0.230 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2022 | 90 | 0.220 |
Why?
|
| Muscular Dystrophy, Facioscapulohumeral | 1 | 2022 | 61 | 0.220 |
Why?
|
| DNA Glycosylases | 3 | 2007 | 20 | 0.210 |
Why?
|
| Neoplasms | 1 | 2007 | 922 | 0.190 |
Why?
|
| Yugoslavia | 1 | 2015 | 1 | 0.150 |
Why?
|
| Streptomyces | 1 | 2015 | 13 | 0.150 |
Why?
|
| History, 21st Century | 1 | 2015 | 140 | 0.140 |
Why?
|
| Ribonuclease III | 1 | 2014 | 75 | 0.140 |
Why?
|
| Mice | 5 | 2022 | 8946 | 0.140 |
Why?
|
| Carcinoma, Basal Cell | 1 | 2014 | 59 | 0.140 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2014 | 73 | 0.130 |
Why?
|
| History, 20th Century | 1 | 2015 | 224 | 0.130 |
Why?
|
| Carcinogenesis | 1 | 2014 | 100 | 0.130 |
Why?
|
| N-Glycosyl Hydrolases | 2 | 2003 | 11 | 0.130 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2014 | 130 | 0.130 |
Why?
|
| Cell Survival | 2 | 2007 | 520 | 0.130 |
Why?
|
| Animals | 6 | 2022 | 17792 | 0.120 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2014 | 444 | 0.110 |
Why?
|
| Escherichia coli | 2 | 2007 | 668 | 0.100 |
Why?
|
| Skin Neoplasms | 1 | 2014 | 338 | 0.100 |
Why?
|
| Ploidies | 1 | 2007 | 3 | 0.090 |
Why?
|
| Centrosome | 1 | 2008 | 74 | 0.090 |
Why?
|
| Chromosomes, Mammalian | 1 | 2007 | 28 | 0.090 |
Why?
|
| Cell Division | 1 | 2008 | 429 | 0.080 |
Why?
|
| Embryo, Mammalian | 1 | 2007 | 152 | 0.080 |
Why?
|
| Molecular Conformation | 1 | 2007 | 111 | 0.080 |
Why?
|
| Luciferases | 1 | 2007 | 103 | 0.080 |
Why?
|
| Spindle Apparatus | 1 | 2007 | 119 | 0.080 |
Why?
|
| Mutagenesis | 1 | 2007 | 135 | 0.080 |
Why?
|
| Models, Chemical | 1 | 2007 | 131 | 0.080 |
Why?
|
| Humans | 6 | 2022 | 48105 | 0.070 |
Why?
|
| Nitrosourea Compounds | 1 | 2003 | 2 | 0.070 |
Why?
|
| Cell Proliferation | 1 | 2007 | 876 | 0.060 |
Why?
|
| HL-60 Cells | 1 | 2002 | 18 | 0.060 |
Why?
|
| Bromodeoxyuridine | 1 | 2002 | 43 | 0.060 |
Why?
|
| DNA, Neoplasm | 1 | 2002 | 50 | 0.060 |
Why?
|
| Models, Molecular | 1 | 2007 | 1069 | 0.060 |
Why?
|
| PAX3 Transcription Factor | 1 | 2022 | 11 | 0.060 |
Why?
|
| Glioma | 1 | 2002 | 90 | 0.060 |
Why?
|
| Muscle Development | 1 | 2022 | 54 | 0.060 |
Why?
|
| Regeneration | 1 | 2022 | 83 | 0.060 |
Why?
|
| Cell Lineage | 1 | 2022 | 241 | 0.050 |
Why?
|
| Recovery of Function | 1 | 2022 | 192 | 0.050 |
Why?
|
| Cell Cycle | 1 | 2002 | 371 | 0.050 |
Why?
|
| Homeodomain Proteins | 1 | 2022 | 237 | 0.050 |
Why?
|
| Recombinant Proteins | 1 | 2002 | 667 | 0.050 |
Why?
|
| Cell Line | 1 | 2022 | 1951 | 0.040 |
Why?
|
| Cells, Cultured | 1 | 2022 | 2036 | 0.040 |
Why?
|
| Cell Differentiation | 1 | 2022 | 1241 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2022 | 1785 | 0.040 |
Why?
|
| Breast Neoplasms | 1 | 2002 | 984 | 0.040 |
Why?
|
| Fetus | 1 | 2014 | 90 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2014 | 243 | 0.030 |
Why?
|
| Hair | 1 | 2014 | 73 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2014 | 487 | 0.030 |
Why?
|
| Substrate Specificity | 2 | 2003 | 313 | 0.030 |
Why?
|
| Skin | 1 | 2014 | 297 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2014 | 1129 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2014 | 595 | 0.030 |
Why?
|
| Apoptosis | 1 | 2014 | 1003 | 0.020 |
Why?
|
| MicroRNAs | 1 | 2014 | 628 | 0.020 |
Why?
|
| Alkylation | 1 | 2002 | 23 | 0.020 |
Why?
|
| Alkylating Agents | 1 | 2002 | 17 | 0.020 |
Why?
|
| DNA Primers | 1 | 2003 | 290 | 0.020 |
Why?
|
| Methylation | 1 | 2002 | 112 | 0.020 |
Why?
|
| Isoenzymes | 1 | 2002 | 127 | 0.020 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2002 | 74 | 0.010 |
Why?
|
| Base Sequence | 1 | 2003 | 1286 | 0.010 |
Why?
|